The FDA has recently approved expanded labeling for diabetes drugs containing metformin. The new labels will now indicate that these medications can be used by some patients living with reduced kidney function. This change came after numerous studies showed that metformin can safely be used with patients who have mild or moderate kidney impairment.
The new labeling rules will affect 18 different drugs. Healthcare professionals will need to follow the latest recommendations when it comes to prescribing these medications to patients living with impaired kidney function. It is also recommended that physicians complete both blood creatinine concentration and glomerular filtration rate estimating equation tests, to determine if a patient is a good candidate to take these medications.
These findings were published in MedPage Today on April 8, 2016.